Log in
Enquire now
‌

US Patent 7803397 Polyethyleneglycol-modified lipid compounds and uses thereof

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7803397
Date of Patent
September 28, 2010
Patent Application Number
10942379
Date Filed
September 15, 2004
Patent Citations Received
‌
US Patent 12129467 Non-liposomal systems for nucleic acid delivery
0
‌
US Patent 12084702 Methods for purification of messenger RNA
0
‌
US Patent 12121592 Lipid nanoparticle compositions and methods for mRNA delivery
0
‌
US Patent 12129223 Lipids for use in lipid nanoparticle formulations
0
‌
US Patent 11712463 MRNA therapy for pompe disease
0
‌
US Patent 11712481 Lipid nanoparticle formulations
0
‌
US Patent 11771652 Lipid nanoparticles for delivering mRNA vaccines
‌
US Patent 11771653 Lipid nanoparticles for delivering mRNA vaccines
...
Patent Primary Examiner
Janet Epps-Smith
Janet Epps-Smith
Patent abstract

The present invention provides compositions comprising polytheylyene-dialkyloxypropyl conjugates (PEG-DAA), liposomes, SNALP, and SPLP comprising such compositions, and methods of using such compositions, liposomes, SNALP, and SPLP.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7803397 Polyethyleneglycol-modified lipid compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us